Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioredoxin Reductase 2 (TXNRD2) is a mitochondrial enzyme that plays a central role in maintaining redox homeostasis within mitochondria. It is essential for scavenging reactive oxygen species (ROS) and protecting cells from oxidative stress. TXNRD2 catalyzes the NADPH-dependent reduction of thioredoxin 2 (Trx2), which acts as an electron donor to peroxiredoxins, detoxifying hydrogen peroxide and peroxynitrite. Deficiency of TXNRD2 has been linked to increased apoptosis and influences differentiation processes.
TXNRD2 catalyzes the NADPH-dependent reduction of thioredoxin 2 (Trx2), which in turn reduces other proteins via cysteine thiol-disulfide exchange reactions. The reduced Trx2 acts as an electron donor to peroxiredoxins, detoxifying hydrogen peroxide and peroxynitrite.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thioredoxin Reductase 2.